Literature DB >> 15933589

Variable outcome of photodynamic therapy for choroidal neovascularization associated with choroidal nevus.

M Battaglia Parodi1, F Boscia, S Piermarocchi, T Micelli Ferrari, C Furino, C Sborgia.   

Abstract

PURPOSE: To report five cases of classic choroidal neovascularization (CNV) associated with choroidal nevus treated with photodynamic therapy (PDT) with verteporfin.
METHODS: The patients underwent an ophthalmologic evaluation, including fluorescein angiography and indocyanine green angiography. Clinical and angiographic data were retrospectively analyzed to evaluate visual acuity outcomes and both clinical evolution and angiographic evolution.
RESULTS: Two patients presented with subfoveal CNV, and three had juxtafoveal CNV. The mean follow-up was 25.8 months. Visual outcomes were extremely variable. Indeed, best-corrected visual acuity decreased in three eyes, stabilized in one case, and improved in the other case. The number of PDT sessions necessary to obtain CNV stabilization with cessation of fluorescein leakage varied from one to six.
CONCLUSION: Bearing in mind that both the natural history and the post-PDT outcome may be extremely variable, further studies are needed to assess the real benefit of PDT for classic CNV secondary to choroidal nevus.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933589     DOI: 10.1097/00006982-200506000-00007

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

Review 1.  Lasers for the treatment of intraocular tumors.

Authors:  Samuel K Houston; Charles C Wykoff; Audina M Berrocal; Ditte J Hess; Timothy G Murray
Journal:  Lasers Med Sci       Date:  2013-05       Impact factor: 3.161

2.  Photodynamic therapy of symptomatic choroidal nevi.

Authors:  Luis Amselem; Kaan Gündüz; Alfredo Adan; Melisa Zişan Karslιoğlu; Amanda Rey; Noelia Sabater; Xavier Valldeperas
Journal:  Middle East Afr J Ophthalmol       Date:  2011-10

3.  Photodynamic therapy for polypoidal choroidal vasculopathy secondary to choroidal nevus.

Authors:  James G Wong; Xin Jie Lai; Richard Y Sarafian; Hon Seng Wong; Jeremy B Smith
Journal:  Int Med Case Rep J       Date:  2017-02-14

4.  Treatment of vascular activity secondary to atypical choroidal nevus using intravitreal bevacizumab.

Authors:  Milena L Cavalcante; Victor M Villegas; Aaron S Gold; Ludimila L Cavalcante; Marcela Lonngi; Nisha V Shah; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2014-07-22

5.  Treatment response to intravitreal bevacizumab in small pigmented choroidal lesions with subretinal fluid.

Authors:  Junwon Lee; Hee Jung Kwon; Min Kim; Christopher Seungkyu Lee; Sung Chul Lee
Journal:  BMC Ophthalmol       Date:  2019-05-03       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.